 to classify risk of amputation and
likelihood of beneﬁt from revascularization by subcategorizing patients into two groups: ischemic rest pain and tissue
loss. Due to demographic shifts over the last 40 years, especially a dramatic rise in the incidence of diabetes mellitus and
rapidly expanding techniques of revascularization, it has become increasingly difﬁcult to perform meaningful outcomes
analysis for patients with threatened limbs using these existing classiﬁcation systems. Particularly in patients